EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Carrier‐Free Nanocapsule with Dual‐Target Capacity for Synergistically Restoring Inflammatory Microenvironment and Microbiota Dysbiosis in Colitis

Yingjie Chen, Yuhan Gao, Kaiyuan Huo, Zhaofan Jin, Wenchao Wang, Xingjie Zan, Yanlong Liu iD, Limeng Zhu, Jianfeng Yang

Advanced Science · 2025-10 · 12 (38)

DOI: 10.1002/advs.202500001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 12.07.2025. Verfasst von Yingjie Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cixi Biomedical Research Institute, Wenzhou Medical University, Ningbo, Zhejiang, 315300, China. Hauptthemen laut MEDLINE: Dysbiosis, Colitis, Gastrointestinal Microbiome, Nanocapsules. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wenzhou Institute of UCAS, Wenzhou Science and Technology Project, Key Discipline of Integrated Chinese and Western Medicine in Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is a chronic inflammatory disease with limited therapeutic outcomes. Macrophages are the key gatekeepers of intestinal immune homeostasis and have vital influence on IBD. Hence, macrophages are recognized as attractive targets to develop new therapeutic. However, the therapy development has proven challenging due to the malignant biological chain between macrophage immune hyperresponsiveness and dysbiosis of intestinal microflora. Herein, a carrier‐free nano‐drug, PCNPs@PEG‐Man, with dual‐targeting function, is produced due to IBD lesion‐specific positive charge and high expression of mannose receptor. With super resistance against extreme intraluminal conditions, PCNPs@PEG‐Man showes stable ROS‐scavenging properties thereby. Notably, the dual‐targeting strategy enhances the endocytosis efficiency and intestinal retention time of the drug, which is conducive to the downregulation of pro‐inflammatory factors, upregulation of anti‐inflammatory factors, and repair of the intestinal barrier. Additionally, it reshaped the dysbiosis of intestinal bacteria, revealing an optimized gut flora composition of probiotics. The mechanism of the carrier‐free nano‐drug mainly involves the elimination of oxidative stress, promoting macrophage M2 polarization, and restoring gut homeostasis. The synergistic effect inherent in this dual‐targeting system presents an effective and safe approach to managing IBD, providing new insights into the treatment of intestinal ROS‐mediated diseases associated with microbiota dysbiosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DysbiosisColitisGastrointestinal MicrobiomeNanocapsulesInflammatory Bowel DiseasesAnimalsMiceMacrophagesHumansDisease Models, AnimalInflammationMice, Inbred C57BL

Stichwörter der Autor:innen

Dual‐targeting strategyGut homeostasisInflammatory bowel diseaseROS scavenging

Substanzen

Nanocapsules

Autor:innen und Institutionen

  • Cixi Biomedical Research Institute, Wenzhou Medical University, Ningbo, Zhejiang, 315300, China.
  • Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, 325001, China.
  • Postgraduate training base Alliance of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China.
  • School of Pharmacy, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
  • School of Mental Health, Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China.
  • Department of Gastroenterology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang, 310000, China.

ORCID-Profile: Yanlong Liu

Förderung

  • Wenzhou Institute of UCAS
  • Wenzhou Science and Technology Project
  • Key Discipline of Integrated Chinese and Western Medicine in Zhejiang Province
  • The Construction Fund of Key Medical Disciplines of Hangzhou
  • Zhejiang Provincial Natural Science Foundation of China

Zitieren

APA

Chen, Y., Gao, Y., Huo, K., Jin, Z., Wang, W., Zan, X., Liu, Y., Zhu, L., & Yang, J. (2025). Carrier‐Free Nanocapsule with Dual‐Target Capacity for Synergistically Restoring Inflammatory Microenvironment and Microbiota Dysbiosis in Colitis. Advanced Science, 12(38). https://doi.org/10.1002/advs.202500001

Vancouver

Chen Y, Gao Y, Huo K, Jin Z, Wang W, Zan X, et al. Carrier‐Free Nanocapsule with Dual‐Target Capacity for Synergistically Restoring Inflammatory Microenvironment and Microbiota Dysbiosis in Colitis. Advanced Science. 2025;12(38). doi:10.1002/advs.202500001

BibTeX
@article{Chen2025,
  author = {Chen, Yingjie and Gao, Yuhan and Huo, Kaiyuan and Jin, Zhaofan and Wang, Wenchao and Zan, Xingjie and Liu, Yanlong and Zhu, Limeng and Yang, Jianfeng},
  title = {Carrier‐Free Nanocapsule with Dual‐Target Capacity for Synergistically Restoring Inflammatory Microenvironment and Microbiota Dysbiosis in Colitis},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {38},
  doi = {10.1002/advs.202500001}
}
Kostenlos starten →